New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
09:24 EDTKOOLThermogenesis raises $6.67M in a private placement
Thermogenesis announced that it has entered into definitive agreements with institutional investors in connection with a private placement of common stock and warrants to purchase common stock. Upon the closing of this financing, ThermoGenesis will receive gross proceeds of approximately $6.67 million resulting from the issuance and sale of approximately 3.33M shares of common stock at a price per share of $2.00. The purchasers will also receive warrants to purchase up to approximately 1.66M shares of common stock at an exercise price of $2.81 per share. The warrants are non-exercisable for six months after the closing of the financing and have a term of 5 years.
News For KOOL From The Last 14 Days
Check below for free stories on KOOL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2014
12:00 EDTKOOLCesca Therapeutics rises 25.6%
Cesca Therapeutics is up 25.6%, or 41c, to $2.01
10:00 EDTKOOLCesca Therapeutics rises 28.8%
Cesca Therapeutics is up 28.8%, or 46c, to $2.06
10:00 EDTKOOLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:22 EDTKOOLCesca Therapeutics initiated with a Buy at Maxim
Subscribe for More Information
April 16, 2014
09:21 EDTKOOLCesca Therapeutics restructures sales and marketing section
Cesca Therapeutics announced the restructuring of its sales, marketing and technical support organization and the appointment of Tim Lee as Director of International Sales. The restructuring will realign Hal Baker from his current role as VP of Commercial Operations, to an external consulting and advisory role, which will ensure an orderly transition of his existing responsibilities with specific attention given to cord blood sales and marketing initiatives. In the newly formed role, Director of International Sales, Mr. Lee's primary focus will be to lead global cord blood product sales and services. Mr. Lee has been involved with the medical and therapeutic research instrument industry for over 20 years.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use